[HER2-Positive Breast Cancer Brain Metastasis Recurred after Whole-Brain Radiotherapy and Successfully Treated with Trastuzumab Deruxtecan] [0.03%]
[接受全脑放疗后复发的 HER2 阳性乳腺癌脑转移灶患者使用德鲁替康成功治疗]
Sara Ozaki,Naoko Iwamoto,Miho Miyake et al.
Sara Ozaki et al.
A 50-year-old female patient noticed a mass and pain in her left breast, and needle biopsy revealed mucinous carcinoma that was negative for hormone receptors and positive for HER2/neu. After further examination, she was diagnosed with left...
Case Reports
Gan to kagaku ryoho. Cancer & chemotherapy. 2026 Jun;53(6):418-421. DOI: 2026
[Employment Status Breast Cancer Patients Received Dose-Dense EC (Epirubicin plus Cyclophosphamide) Therapy] [0.03%]
接受密集化疗表阿霉素+环磷酰胺乳腺癌患者的就业情况
Yoshitake Shinohara,Yuzuru Inoue,Yuko Tashima et al.
Yoshitake Shinohara et al.
Purpose: To support the employment of breast cancer patients, it is important to reveal the factors that influence the side effects of chemotherapy on employment. However, there are still a few reports on the factors rega...
[Outcome of Eight-Year-Experiences of BCG Intravesical Instillation Therapy in Patients with Non-Muscle Invasive Bladder Cancer in Asahikawa Medical University Hospital] [0.03%]
[Akahira医科大学医院八例膀胱内注射BCG治疗浅肌层膀胱癌疗效观察]
Junichi Hori,Masayuki Tokumitsu,Satoshi Yamaguchi et al.
Junichi Hori et al.
We retrospectively investigated the outcome of BCG intravesical instillation therapy for patients with non-muscle invasive bladder cancer. From 2011 to 2019, a total of 79 patients had received BCG intravesical instillation therapy for non-...
Kenichi Morooka
Kenichi Morooka
Cytodiagnosis is an effective screening method for early cancer detection. In cytodiagnosis, a cytotechnologist examines cell specimens collected from the target organ under a microscope. The cytotechnologist diagnose cancer by identifying ...
[Frontiers in Research, Development, and Clinical Application of AI-SaMDs] [0.03%]
[人工智能医疗器械的研究、开发与临床应用前沿]
Tomonori Taniguchi,Masaaki Komatsu,Ryuji Hamamoto
Tomonori Taniguchi
Artificial intelligence (AI) technologies are rapidly being introduced into the medical device field, particularly in the form of software as a medical device (AI-SaMD), for which regulatory approvals are increasing. In the United States an...
[AI in Cancer Pathology-Present Developments and Future Directions for Treatment Optimization] [0.03%]
人工智能在癌症病理学中的现状和发展趋势及其对未来治疗优化的影响
Maki Takao,Daisuke Komura,Shumpei Ishikawa
Maki Takao
Recent advances in artificial intelligence (AI) technologies have substantially expanded the role of pathological image analysis beyond improvements in diagnostic accuracy and efficiency. These developments now enable the integration of his...
[Therapeutic Targets by Pathology AI and Spatial Transcriptomics in Breast Cancer] [0.03%]
[病理AI和空间转录组学在乳腺癌治疗靶点中的应用]
Maki Tanioka
Maki Tanioka
Recent advances in pathology foundation models have markedly improved the accuracy and generalizability of histopathological image analysis in breast cancer. However, the mechanisms of resistance to CDK4/6 inhibitors in hormone receptor-pos...
[Creation of Patient Summaries from Electronic Medical Records and Integration of Medical Knowledge via Large Language Models-Next-Generation Medical DX and Drug Discovery Support Opened Up by Natural Language Processing] [0.03%]
基于电子病历生成患者概述和通过大型语言模型整合医学知识——自然语言处理开启下一代医疗诊断及药物发现支持
Gen Tamiya
Gen Tamiya
In Japan, the adoption rate of electronic medical records (EMR) in general hospitals has surpassed 50%, leading to the rapid digitization of medical information. However, core components such as clinical notes and nursing records remain acc...
[Management of ICANS in Patient Treated with Anti-CD19 CAR T-Cell Therapy] [0.03%]
CAR-T细胞治疗后ICANS的管理
Risa Nishiyama,Shinichi Makita
Risa Nishiyama
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has been established as a standard of care in selected patients with relapsed or refractory large B-cell lymphoma (LBCL). Unlike conventional cytotoxic chemotherapy, CAR T-cell therap...
Tomoharu Ishiyama,Akira Jingu,Hidekazu Matsumoto
Tomoharu Ishiyama
Case 1: A 64-year-old woman underwent mastectomy for left breast cancer. A CT scan 5 years 9 months postoperative showed abdominal wall swelling, irregular soft tissue tumor, and irregular peritoneal thickening. She received chemotherapy fo...
Case Reports
Gan to kagaku ryoho. Cancer & chemotherapy. 2026 Jul;53(7):474-475. DOI: 2026